UBS Group AG (UBS)
UBS taps Allianz GI Asia head Desmond Ng to lead Asia-Pacific asset management unit
The asset management arm of Swiss bank UBS said on Thursday it has appointed Desmond Ng as its Asia-Pacific head, effective October 1.
UBS Analysts Believe In Starbucks' CEO—And Its Turnaround Plan
Starbucks stock has frothier days ahead.
Here's Why UBS (UBS) is a Strong Value Stock
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
UBS Group: A Solid Bank Trading At A Fair Price
Relative valuation is neutral, absolute valuation is slightly bullish with a $37 target price, reflecting a 10% upside. UBS is a solid, leading Swiss bank with potential profitability improvements from the Credit Suisse merger, yet growth remains modest and in line with the industry. The Investment Banking segment is showing green shoots.
UBS Capital Requirements Rise Following Switzerland's Proposal
UBS pushes back as Switzerland proposes an $18-billion net capital hike to prevent another Credit Suisse-style crisis.
US recession risk: Is the UK about to catch a cold?
There’s a reason the old cliché about America sneezing still gets wheeled out: it holds up. A new note from UBS flags that recession risks in the United States are quietly ticking higher again, and while nothing’s broken yet, the cracks are starting to show. UBS tracks three main recession indicators: real-world data, credit conditions and the shape of the US yield curve. And all of them are moving in the same direction. Not alarmingly so, but enough to suggest the so-called “soft landing” might not be the final word on the story. Real-world Let’s start with the real economy. UBS’s preferred tracker is built entirely from hard data: production, employment, capital spending, housing, income and consumption. Not a PMI or sentiment survey in sight. This model had flagged trouble back in 2022, only to reverse course in late 2023 as the economy stabilised. But that recovery has since fizzled out. April data, in particular, showed broad-based weakness across all the usual suspects. As a result, UBS now pegs the US recession probability from this model at 46%, up a chunky 12 percentage points in a single month. Troublesome bond market Next up is the yield curve, the time-honoured market signal where investors look at the gap between short- and long-dated Treasury yields. After two years flashing red, that warning light had dimmed. But now it’s glowing again, albeit faintly. According to UBS, the yield curve is currently implying a recession probability of 18%. That’s a far cry from the extremes of last year, but still a notable uptick. Then there’s credit. UBS’s credit-based model, which looks at financial ratios and lending conditions, didn’t fall into the same trap as the yield curve during the false alarm of 2022–24. It held steady. But even that has now started to shift. The model has climbed to a 48 per cent probability—the highest level since the pandemic. Don't press the panic button...yet Put it all together and UBS’s composite gauge puts the US recession risk at 37 per cent. That’s up from 26 per cent in December and, crucially, closing in on the kind of levels that have historically preceded actual downturns. To be clear, no one at UBS is calling a recession yet. The team stresses that the economy started this year on “okay footing”, but warns that “data deterioration could bring back discussion of recession risks”. What’s more, a lot of these shifts happened before the full impact of Donald Trump’s tariffs is likely to be felt. If those start to bite, the probability numbers could push higher still. Still the world engine for demand For those watching from this side of the Atlantic, the message is pretty simple. The US consumer is still the engine of global demand. If they do start to retrench (or if businesses start scaling back investment) there’s little chance the rest of the developed world comes out unscathed. For now, the lights are flashing amber. But it’s worth keeping a close eye on May and June’s data. If the slowdown starts to look more entrenched, expect the market narrative to shift fast, from soft landing to something a lot bumpier. Polarean Imaging PLC (AIM:POLX, OTC:PLLWF) shares rose 7% in afternoon trading after the company received US regulatory approval to expand the use of its lung imaging agent, XENOVIEW, to children as young as six. The decision by the Food and Drug Administration lowers the age threshold from 12, potentially opening access to around one million additional patients. XENOVIEW, used in MRI scans to measure lung ventilation without radiation, will now be available for younger patients with chronic respiratory conditions. Polarean will also roll out new dose delivery bags tailored to paediatric use, along with updated equipment to ensure accurate gas measurements for smaller lungs. The company said the move marks a significant step in broadening access to advanced lung imaging, while also improving the technology’s appeal to hospitals. A targeted launch of the paediatric system will begin later this year, starting with Cincinnati Children’s Hospital. The stock rose 0.085p to 1.36p.
UBS Group's Arm to Divest O'Connor Business to Cantor Fitzgerald
UBS' arm is set to sell its $11B O'Connor unit to Cantor Fitzgerald, sharpening its focus post-Credit Suisse merger amid Swiss capital pressures.
Why Is UBS (UBS) Up 5% Since Last Earnings Report?
UBS (UBS) reported earnings 30 days ago. What's next for the stock?
Five reasons why BT remains a sell for UBS
BT Group PLC (LSE:BT.A) was reiterated as a 'sell' by UBS following its fourth-quarter results, with the bank counting off five underappreciated risks that could weigh on performance in the near term. UBS analyst Polo Tang, who maintained his 12-month price target of 120p that implied a downside of 31.43% from the 175p share price at the start of the week, noted that while free cash flow guidance was held steady, this is based on an optimistic assumption that revenues will grow from the 2027 financial year.
UBS Group AG Outlook Upgrades to Positive by Fitch, Affirms IDR at 'A'
UBS outlook upgrade by Fitch to Positive cites smooth Credit Suisse integration, rising profitability, and strong capital and liquidity metrics.
Top Swiss court rules against claim by two former Credit Suisse shareholders
Switzerland's supreme court on Friday ruled against a compensation claim by two former shareholders of Credit Suisse who bought stock in the bank shortly before it failed in March 2023, saddling them with hefty losses.
'As of today, we are a Swiss organization', says UBS' Iqbal Khan
Iqbal Khan, Co-President of UBS Global Wealth Management says the bank will work "proactively and reactively" through the capital proposal that the Swiss regulator will put forward in June.
